Navigation Links
Society for Biological Engineering Holds First International Conference on Stem Cell Engineering
Date:1/16/2008

NEW YORK, Jan. 16 /PRNewswire/ -- With the field of stem cells an ever- more important area of research, the Society for Biological Engineering (SBE) has organized the First International Conference on Stem Cell Engineering. The conference, which runs from January 20th to 23rd at the Coronado Island Marriott Resort, Coronado Island, California, will focus on engineering designs for stem cell production, moving from the laboratory to bioprocesses for usable stem cell therapeutics.

Among other topics, speakers will describe advances in the understanding of biological mechanisms that underlie stem cell processes, the technologies employed to study stem cell function, and the development of bioprocesses to culture stem cells for commercial applications.

Keynote speakers include:

-- George Daily, associate director of the Stem Cell Program at Children's

Hospital in Boston

-- Douglass Lauffenburger, professor and chair of the Department of

Biological Engineering at the Massachusetts Institute of Technology

-- Irving Weissman, professor in the Departments of Pathology and

Developmental Biology at Stanford University

"To improve healthcare, biologists and engineers need to work together, and this is especially true in the area of stem cell science and technology," said June Wispelwey, SBE's executive director. She added: "We're holding this conference because stem cells hold so much promise, but there's also so much to be done in terms of propagating stem cells, and applying what we know to tissue engineering, cell therapy, and drug development."

About SBE:

The Society for Biological Engineering is a technological community for engineers and applied scientists integrating biology with engineering. It was established by the American Institute of Chemical Engineers (AIChE), in 2004. Members of SBE come from a broad spectrum of industries and disciplines and share in SBE's mission of realizing the benefits of bioprocessing, biomedical and biomolecular applications. http://bio.aiche.org. Executive Director: June Wispelwey, bio@aiche.org.

About AIChE:

AIChE, celebrating its 100th anniversary in 2008, is a professional association of 40,000 chemical engineers in 92 countries. Its members work in corporations, universities and government using their knowledge of chemical processes to develop safe and useful products for the benefit of society. For more information about the conference and AIChE, please go to http://www.aiche.org.

Contact: Jeanette Krebs

Phone: (717) 214-2200

Email: krebs@thebravogroup.com


'/>"/>
SOURCE Society for Biological Engineering
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics
2. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
3. 49th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases
4. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
5. Three Astex Drug Candidates to be Presented at the 2007 American Society of Hematology Annual Meeting
6. Syngenta and The Royal Society of Chemistry Launch African Science Initiative
7. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
8. Dr. Dinesh Verma to be honored with Presidents Leadership Award at Edwin A. Stevens Society Gala
9. Sangamo BioSciences Announces ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting
10. Proteon Therapeutics to Present at Annual Meeting of American Society of Nephrology in San Francisco on November 2, 2007
11. Nikon Unveils the Eclipse Ti Inverted Microscope Series at The Society for Neroscience Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... HILL, N.C. , Feb. 5, 2016  In ... key role for a host of launch activities including ... importance of this launch activity is especially high in ... specialists. Best Practices and the Role of ... will help companies focused on oncology therapies find better ...
(Date:2/4/2016)... Massachusetts , February 4, 2016 - New FDA ... - New FDA action date of July 22, ... of July 22, 2016   - ... U.S. in the past decade indicated for the treatment of signs and symptoms ... Lifitegrast has the potential to be the only product approved in the U.S. ...
(Date:2/4/2016)... Feb. 4, 2016  CytoSorbents Corporation (NASDAQ: ... its flagship CytoSorb® blood filter to treat deadly ... the world, announced that CEO Dr. Phillip ... Source Capital Group,s 2016 Disruptive Growth & Healthcare ... company.  Conference Presentation Details: ...
(Date:2/4/2016)... -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... in China , today announced that ... on February 4, 2016 a preliminary non-binding proposal letter, ... PKU V-Ming ( Shanghai ) Investment Holdings ... ( Shenzhen ) Fund Management Co., Ltd., ...
Breaking Biology Technology:
(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
(Date:1/11/2016)... SAN JOSE, Calif. , Jan. 11, 2016 /PRNewswire/ ... developer of human interface solutions, today announced that its ... display driver integration (TDDI) products won two separate categories ... including Best Mobile Innovator and Best Technology Breakthrough. The ... overall system cost, a simplified supply chain, thinner devices, ...
(Date:1/7/2016)... Various factors have contributed to the ... biologics and biosimilars. Some of these factors include ... demand for cost-effective alternatives, growing burden of chronic ... versions of their corresponding patented biologic drugs, and ... and efficacy. The global biosimilars market is estimated ...
Breaking Biology News(10 mins):